Dysport (Ipsen Biopharmaceuticals, Inc.)
Welcome to the PulseAid listing for the Dysport drug offered from Ipsen Biopharmaceuticals, Inc.. This Acetylcholine Release Inhibitor [EPC],Acetylcholine Release Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Ipsen Biopharmaceuticals, Inc. |
NON-PROPRIETARY NAME: | Botulinum Toxin Type A |
SUBSTANCE NAME: | BOTULINUM TOXIN TYPE A |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Acetylcholine Release Inhibitor [EPC],Acetylcholine Release Inhibitors [MoA] |
ROUTE: | INTRAMUSCULAR |
DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
MARKETING CATEGORY NAME: | BLA |
START MARKETING DATE: | 2009-11-02 |
END MARKETING DATE: | 0000-00-00 |
Dysport HUMAN PRESCRIPTION DRUG Details:
Item Description | Dysport from Ipsen Biopharmaceuticals, Inc. |
LABELER NAME: | Ipsen Biopharmaceuticals, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 500(U/1) |
START MARKETING DATE: | 2009-11-02 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 15054-0500_f0cc4070-ca90-4f6f-8846-7f197926e4fc |
PRODUCT NDC: | 15054-0500 |
APPLICATION NUMBER: | BLA125274 |
Other BOTULINUM TOXIN TYPE A Pharmaceutical Manufacturers / Labelers: